×
For best experience we recommend to activate Javascript in your browser.
MAPT antibody (AA 167-266)
The Mouse Monoclonal anti-MAPT antibody (Clone 3A16) (ABIN2752327) specifically detects MAPT in WB and ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN2752327
$415.77
$489.14
save $73.37 (-15 %)
Plus shipping costs $50.00
Delivery in 11 to 12 Business Days
Quick Overview for MAPT antibody (AA 167-266) (ABIN2752327)
Target
See all MAPT Antibodies
MAPT
(Microtubule-Associated Protein tau (MAPT))
Reactivity
All reactivities for MAPT antibodies
Human
Host
All hosts for MAPT antibodies
Mouse
Clonality
All clonalities for MAPT antibodies
Monoclonal
Conjugate
All conjugates for MAPT antibodies
This MAPT antibody is un-conjugated
Application
All applications for MAPT antibodies
Western Blotting (WB), ELISA
Clone
3A16
Product Details anti-MAPT Antibody
(hide)
Binding Specificity
All epitopes for MAPT antibodies
AA 167-266
Purpose
Mouse monoclonal antibody raised against a partial recombinant MAPT.
Sequence
TRQPSGTGPE DTEGGRHAPE LLKHQLLGDL HQEGPPLKGA GGKERPGSKE EVDEDRDVDE SSPQDSPPSK ASPAQDGRPP QTAAREATSI PGFPAEGAIP
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
MAPT (NP_058519.2, 167 a.a. ~ 266 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Buffer
In 1x PBS, pH 7.4
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Target Details for MAPT
(hide)
Target
MAPT
(Microtubule-Associated Protein tau (MAPT))
Alternative Name
MAPT
Background
Full Gene Name: microtubule-associated protein tau Synonyms: DDPAC,FLJ31424,FTDP-17,MAPTL,MGC138549,MSTD,MTBT1,MTBT2,PPND,TAU
Gene ID
4137
NCBI Accession
NM_016835
Pathways
MAPK Signaling , Microtubule Dynamics , M Phase , Regulation of Cell Size
Recently viewed
(hide)
Chat with us , powered by LiveChat